Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

ORTHO REGENERATIVE TECHNOLOGIES $ORTH.ca $ORTIF ADDS PATRICK O’DONNELL TO BOARD OF DIRECTORS

Posted by AGORACOM at 11:40 AM on Thursday, February 25th, 2021
Ortho

Montreal, QC, February 24, 2021 – Ortho Regenerative Technologies Inc. (CSE: ORTH, OTCQB: ORTIF) (“Ortho RTI” or the “Company”), a clinical stage orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced today the appointment of Patrick O’Donnell to its Board of Directors, effective immediately. 

“We are very pleased to welcome Patrick to the Ortho RTI Board of Directors to help lead a very important transition in the development of our company, as we prepare to start our first U.S. multisite Ortho-R rotator cuff tear repair Phase I/II clinical trial”, said Claude LeDuc, President and Chief Executive Officer of Ortho RTI. “Ortho RTI will greatly benefit from Patrick’s company-building experience as well as his expertise in the development and management of strategic partnerships fund-raising, commercial, clinical, regulatory and reimbursement strategies, all specific to our industry. We are looking forward to his insightful contribution to our Board”. 

Commenting on his appointment to Ortho RTI’s Board of Directors, Mr. O’Donnell said: “I am happy to be joining the Board of Directors of Ortho RTI. The Company’s proprietary technology platform has the potential to help address significant unmet medical needs in a multitude of soft tissue repair related indications. I am excited to help Ortho RTI develop into an orthobiologics industry leader”. 

Read More: https://agoracom.com/ir/OrthoRegenerativeTechnologies/forums/discussion/topics/755959-ortho-regenerative-technologies-adds-patrick-o-donnell-to-board-of-directors/messages/2305098#message

Mountain Valley MD $MVMD $MVMDF Confirms Quicksome™ License Agreement, First Revenues $CTLT $MRNA $NVAX

Posted by AGORACOM at 9:18 AM on Thursday, February 25th, 2021
This image has an empty alt attribute; its file name is MVMD-Small.png
  • Entered a commercial license agreement with that is focused on the rapidly emerging global mushroom space.
  • Based on applying MVMD’s Quicksome™ technology to mushroom nutraceutical products
  • Initial payment in the amount of $250,000 CAD

Mountain Valley MD Holdings Inc. (the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce that Mountain Valley MD Inc. (“Mountain Valley“) has finalized and entered into a commercial license agreement with Circadian Wellness Corp. (“Circadian“), a privately held Ontario corporation that is focused on the rapidly emerging global mushroom space.

The license agreement with Circadian is based on applying MVMD’s Quicksome™ technology to mushroom nutraceutical products in consideration of ongoing product royalties and an initial payment in the amount of $250,000 CAD, made up of $200,000 CAD cash and $50,000 CAD of equity shares in Circadian.  The initial payment monies will be applied to formulation, product development and sample development work and represents the Company’s first revenues.

MVMD has been working closely with Circadian on proprietary formulations for mushroom-infused products that achieved a significant increase in overall molecule efficacy with the Company’s Quicksome™ desiccated liposome technology applied across a variety of rapid dissolve oral products.  Circadian is finalizing its product plans and go-to-market strategy for a broad line of naturally derived mushroom products that will be distributed initially in North America and expanded globally in future phases.

“Embedding Mountain Valley MD’s Quicksome™ technology into our unique mushroom product formulations has allowed us to create a product line that we believe will be unmatched in its efficacy in the marketplace,” stated Dr. Sanjeev Goel, Chief Medical Officer at Circadian Wellness and founder of Peak Human Labs. “The initial consumer testing with our energy and sleep products has been very well received.  The precision of this delivery technology allows us to build the functional mushroom business out while simultaneously pursuing a leadership position in the rapidly emerging psychedelic space.”

Circadian is a privately held Ontario corporation in the business of mushroom cultivation, extraction, clinical research and development, and end-user consumer health and wellness products and retreats (www.circadianwellness.com).

“With our focus on providing our global nutraceutical, vaccine and pharmaceutical partners with unprecedented product and market advantages, we believe our partnership with Circadian Wellness is a perfect bullseye for our value proposition across the health and wellness space,” stated Dennis Hancock, President and CEO of Mountain Valley MD.  “This inroad into the rapidly growing mushroom industry timed with the broadening analyst coverage of the numerous scientific benefits of mushrooms on human health are expected to be significant for our business plan at Mountain Valley MD.”

“Our ability to drive an increase in bioavailability across convenient and easy-to-use rapid dissolve oral delivery formats provides numerous product advantages that we believe will position Circadian Wellness products as the preeminent choice for consumers in the rapidly growing mushroom marketplace,” stated Mike Farber, Director of Life Sciences at Mountain Valley MD.

Read More: https://agoracom.com/ir/MountainValleyMD/forums/discussion/topics/756066-mountain-valley-md-confirms-quicksome-license-agreement-first-revenues/messages/2305344#message

Red Light Holland $TRIP.ca $TRUFF iMicrodose Pack Receives Authorization for the First Legal Import and Sale of Psilocybin Truffles to Brazil $RVV.ca $PSYC $FTRP $BUZZ

Posted by AGORACOM at 8:53 AM on Thursday, February 25th, 2021
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg
  • iMicrodose packs, which contain 15g of Psilocybin Truffles, to be legally imported to Brazil
  • To be imported and sold in Brazil for Medical use
  • Approval and shipment represent a significant advancement in opening the legal and medically approved market for psilocybin in Brazil

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is extremely pleased to announce that Anvisa, Brazil’s National Health Regulatory Agency, has granted authorization for the Company’s iMicrodose packs, which contain 15g of Psilocybin Truffles, to be legally imported to Brazil via the ‘named patient import process’ for prescribed medical patient use.

“We are grateful for our collaborative relationship with Disruptive Pharma who worked closely with the Brazilian Health Regulatory Agency to secure authorization to import Red Light Holland’s iMicrodose packs, with our natural-occurring branded Psilocybin Truffles, to be imported and sold in Brazil for Medical use, as our branded iMicrodose packs have officially been prescribed by a doctor to a patient in Brazil,” said Todd Shapiro, CEO and Director of Red Light Holland. “This is a monumental day for the Company, and we are so proud to be a part of providing legal access of psilocybin to Brazil and for the first time having our product prescribed by a physician for medical use.”

Red Light Holland’s iMicrodose packs have been shipped to Disruptive Pharma’s MyPharma2Go logistics hub in the Netherlands to start their journey to Brazil. Once landed in Brazil, MyPharma2Go is expected to deliver the iMicrodose packs to a Brazilian patient as they have been pre-prescribed by a physician, before the end of March 2021.

This approval and shipment represent a significant advancement in opening the legal and medically approved market for psilocybin in Brazil, a country with a population of over 200 million people. Shapiro added: “This early process working alongside Disruptive Pharma’s MyPharma2Go.com, a large Brazilian online pharmaceutical and supplement distributor, has been an absolute pleasure and one we are thankful for. We are pleased to do our part to potentially be a part of positive change in Brazil, and to steal a line from Neil Armstrong: This is one micro step for man, one macro leap for mankind.”

Red Light Holland and Disruptive Pharma continue to work towards finalizing their proposed joint venture structure and agreement, as previously disclosed in the Company’s news release dated December 14, 2020. In consideration for Disruptive Pharma having met these initial milestones, the Company has agreed to issue to Disruptive Pharma, 3,000,000 common share purchase warrants, each warrant is exercisable into one common share of the Company at a price of $0.50 per share for a period of 2 years. 750,000 of these warrants have vested immediately based on Disruptive Pharma having fulfilled these milestones, the balance vest upon future milestones being met. These warrants and any underlying shares issued upon exercise, are subject to a statutory hold period of 4 months and 1 day.

Read More: https://agoracom.com/ir/RedLightHolland/forums/discussion/topics/756065-red-light-holland-imicrodose-pack-receives-authorization-for-the-first-legal-import-and-sale-of-psilocybin-truffles-to-brazil/messages/2305343#message

Xali Gold $XGC.ca Delineates Drilling Targets at El Dorado $FMG.ca $MEX.ca $AGI.ca $DSV.ca

Posted by AGORACOM at 8:35 AM on Thursday, February 25th, 2021

Xali Gold Corp. (TSXV:XGC) (“Xali Gold” and/or the “Company”) is pleased to advise that new drill targets have been delineated on the El Dorado Gold-Silver Project, located in Nayarit State, Mexico through the development of a new 3D geological model. The new model indicates high grade mineralization occurring in multiple parallel veins such that future mining could focus on several veins at once to potentially allow reduced mining costs. Drilling is planned to test potential lateral extensions to the high grade zone.

Permitting applications are in progress for the drilling which are expected to take 3 to 4 months to receive. Permit applications are also being prepared for the reopening of the historical Hundida Mine and should take 6 to 10 months to receive. Mineralization is planned to be shipped from this area to the nearby SDA plant under acquisition from Magellan Acquisitions.

The El Dorado vein system has a history of small-scale mining from two veins in the Hundido and El Dorado mines (see News Release April 28, 2020) but four veins with parallel high-grade zones have been delineated in the new model. Additionally, several vein targets have been identified along trend for follow-up exploration.

Prospero Silver Corp. (“Prospero”) explored the El Dorado property between 2010 and 2011. Their drilling intersected multiple steeply-dipping silicified mineralized zones extending from near-surface to the 180 metre (“m”) drilled depth and over a strike length of 440m.   Prospero intersected grades ranging from 3 to 40 grams per tonne (“gpt”) gold and 57 to 500 gpt silver over true widths ranging from 0.52 to 11.2 m. (http://www.candentegold.com/i/maps/sedardoc4391012.pdf)

Significant results reported by Prospero on Dec 10, 2010 included:

  • 16.17m grading 4.03 g/t gold, 204 g/t silver, 4.0% lead, and 1.75% zinc; and 2.32m grading 6.04 g/t gold and 140 g/t silver in hole DOR-10-11. (http://www.candentegold.com/i/maps/Prospero-NR–December-10,-2010.pdf)

Read More: https://agoracom.com/ir/XaliGold/forums/discussion/topics/756062-xali-gold-delineates-drilling-targets-at-el-dorado/messages/2305340#message

Candente Copper $DNT.ca Engages Ausenco for Desk Top Studies on Cañariaco Norte Higher Grade Copper Project $CDG.ca $FCX.ca $TECK.ca $FSUGY $PER.ca

Posted by AGORACOM at 8:30 AM on Thursday, February 25th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/08/candente-copper-for-blog1.jpg

Candente Copper Corp. (TSX:DNT, BVL:DNT) (“Candente Copper”, “Company”) is pleased to announce that it has engaged Ausenco Engineering Canada Inc. (“Ausenco”) to conduct Desk Top Studies to identify and define a smaller, higher grade, start up option for Cañariaco with a smaller initial capital expenditure (“CapEx”) and accelerated payback period. This study is expected to take 4 to 6 weeks to complete.

Assuming favourable results from the Desk Top Studies the Company would look to move into a Preliminary Economic Assessment (“PEA”) on the Revised Project Concept which would be expected to take approximately 4 months to complete. The Company is fully funded for both levels of studies. (for more details please see News Release No. 126 dated February 22nd, 2021).

Ausenco is globally recognised for providing consulting, project delivery, and asset operations services to the international mining sector including high performance copper processing and infrastructure projects. Ausenco has a 30-year track record in delivering specialized end-to-end solutions which are proven to lower capital and operating costs, reduce construction time and improve plant efficiencies.

Ausenco’s project experience ranges from small conceptual studies for new developments through to the construction of large scale minerals processing facilities. In Peru, Ausenco’s experience includes providing Engineering, Procurement and Construction Management services to design, construct, and commission the 25 million tonnes per year concentrator and associated infrastructure for the Constancia Copper Molybdenum Project owned by Hudbay.

Furthermore, Ausenco is currently in the final stages of providing Engineering, Procurement and Construction Management services to design, construct, and commission two processing facilities that will process 6 million tonnes per year of copper sulfide ore and 12 million tonnes per year of oxide ore via solvent extraction and oxide leaching facility (along with associated infrastructure) for the Mina Justa project owned by Marcobre S.A.C. (controlled by Minsur S.A.).

Recently, Mantos Copper Holding has engaged Ausenco for the engineering, procurement and construction (EPC) the 30,000 tonne per day copper concentrator plant and related infrastructure at the Mantoverde Development Project in Chile.

Read More: https://agoracom.com/ir/CandenteCopper/forums/discussion/topics/756063-ausenco-engaged-for-desk-top-studies-on-ca-ariaco-norte-higher-grade-project/messages/2305341#message

Chilean Metals $CMX.ca Closes NISK Acquisition Providing the Company a High-Grade Historical Nickel Copper Cobalt PGE Resource $FCC.ca $CCW.ca $FPX.ca

Posted by AGORACOM at 7:42 AM on Thursday, February 25th, 2021

Chilean Metals Inc. (“Chilean Metals,” “CMX” or the “Company”) (TSXV:CMX)(SSE:CMX)(MILA:CMX) s pleased to announce it has received TSXV conditional approval on its announced agreement to acquire 80% of the NISK property via a series of option payments and work commitments as further detailed below.

Option Terms:

Grant of first option

Critical Elements Lithium Corp. (“Critical Elements”) (CRE)(CRECF)(F12) has granted to Chilean Metals, as the “Optionee”, the exclusive right and option to acquire, on or before the date that is three (3) years from the TSX.V approval (the “Effective Date”) (the “First Option Period“), an initial 50% Earned Interest in the Property (the “First Option“), free and clear of all Encumbrances other than the Permitted Encumbrances and the Royalty, subject to the terms and conditions in this Agreement.

Requirements to Exercise the First Option

In order to acquire the 50% Earned Interest under the First Option, the Optionee must:

a. make cash payments totaling $500,000 to Critical Elements (the “Cash Payments“) on or before the dates set out below:
i. a non-refundable amount of $25,000 on the date of execution of the agreement; (COMPLETED)
ii. an amount of $225,000 within a delay of five (5) Business Days following the Effective Date; and (COMPLETED)
iii. an amount $250,000 within a delay of six (6) months from the Effective Date;
b. issue to Critical Elements within five (5) Business Days following the Effective Date, 12,051,770 Shares (the “Share Payment“) of the Optionee. The Shares issued will be issued as fully paid and non-assessable free and clear of all liens, charges, and Encumbrances, and subject only to a four-month and one-day resale restriction under applicable Securities Laws and the policies of the TSXV;
c. incur an aggregate of $2,800,000 of Work Expenditures on the Property on or before the dates set out below:
i. $500,000 in Work Expenditures on or before the date that is one (1) year from Effective Date;
ii. $800,000 in Work Expenditures on or before the date that is two (2) years from Effective Date; and
iii. $1,500,000 in Work Expenditures on or before the date that is three (3) years from Effective Date; and

Upon the Optionee having completed the Cash Payments, the Share Payment and incurred or funded the Work Expenditures on or before the expiry of the First Option Period, the Optionee may exercise the First Option by delivering notice to Critical Elements to that effect and confirming exercise of the First Option (the “First Option Exercise Notice“). Upon delivery of the First Option Exercise Notice, the Optionee shall have earned a 50% Earned Interest in the Property.

Grant of second option

Subject to the Optionee having exercised the First Option, Critical Elements also grants to the Optionee the exclusive right and option (the “Second Option”) to increase its Earned Interest in and to the Property from 50% to 80% by incurring or funding additional Work Expenditures for an amount of $2,200,000, including the delivery of a Resource Estimate, for a period commencing on the delivery of the First Option Exercise Notice and ending on the date that is four (4) years from Effective Date (the “Second Option Period”).

Following the exercise of the Second Option, until such time as a definitive Feasibility Study (the “Definitive Feasibility Study“) regarding extraction and production activities on the Property is delivered to the Joint Venture, Critical Elements shall maintain a 20% non-dilutive interest in the Joint Venture and shall not contribute to any Joint Venture costs.

Operatorship

During the currency of the Agreement, except as otherwise contemplated under the Agreement, Chilean Metals shall act as the operator (the “Operator“), and as such, shall be responsible for carrying out and administering the Work Expenditures on the Property, in accordance with work programs (the “Programs“) approved by the Technical Committee. The Operator shall be entitled to receive a management fee equal to 10% of the amount of Work Expenditures incurred on internal work and equal to 5% of the amount of Work Expenditures incurred on contract work carried by third-party contractors or consultants.

In the event, Chilean Metals exercises the First Option and subsequently elects not to exercise the Second Option, or in the event, the Second Option is terminated, whichever the case, Chilean Metal’s right to act as Operator shall immediately terminate and Critical Elements shall become the Operator for the future conduct of Work Expenditures and Programs on the Property.

Royalty

Following the exercise of the First Option by Chilean, and in addition to the obligations of Chilean under the First and Second Option, if applicable, Critical Elements shall receive, in the event of a Lithium discovery, a royalty equal to 2% net smelter returns (the “Royalty“) resulting from the extraction and production of Lithium products, including Lithium ore, concentrate and chemical, resulting from the extraction and production activities on the Property, including transformation into chemical products. Chilean shall have the right at any time to purchase 50% of the Royalty and thereby reduce the Royalty to 1% by paying to Critical Elements a total cash amount of $2,000,000.

Read More: https://agoracom.com/ir/ChileanMetals/forums/discussion/topics/756056-chilean-metals-closes-nisk-acquisition-providing-the-company-a-high-grade-historical-nickel-copper-cobalt-pge-resource/messages/2305331#message

Arctic Star $ADD.ca Further Increases Financing to $1.3M $RIO $DIAM.ca $NAR.ca $MPVD.ca

Posted by AGORACOM at 2:10 PM on Wednesday, February 24th, 2021
Arctic star logo
  • Arctic Star Announces Further Increase To Non-Brokered Private Placement
  • Amended the terms of its previously announced financing described in its press releases of Feb. 2, 2021, Feb. 4, 2021, and Feb. 19, 2021
  • Issue up to 26 million units for gross proceeds of up to $1.3-million.

Arctic Star Exploration Corp. has amended the terms of its previously announced financing described in its press releases of Feb. 2, 2021, Feb. 4, 2021, and Feb. 19, 2021. The company previously disclosed that it would issue up to 17 million units at a price of five cents per unit for gross proceeds of $850,000. Due to further increased demand, the company has increased the number of units to be issued, such that it will issue up to 26 million units for gross proceeds of up to $1.3-million.

Each unit will comprise one common share in the capital of the company and one non-transferable share purchase warrant. Each warrant will entitle the holder to purchase one additional share in the capital of the company for a period of 24 months from the closing date at an exercise price of 10 cents.

All securities will be subject to a four-month hold period from the closing date. The private placement is subject to TSX Venture Exchange approval.

The company intends to use the proceeds from the private placement for exploration on the Diagras diamond project and for general working capital.

Loncor $LN.ca $LONCF Defines Four Extensive Mineralized Trends Southeast of Key Adumbi Deposit $ABX $NGT $GOLD $TECK

Posted by AGORACOM at 9:54 AM on Wednesday, February 24th, 2021
This image has an empty alt attribute; its file name is Loncor-Small-Square.png
  • Targets Identified at Imbo East
  • Early Stage Exploration Identified 4 Mineralized Trends
  • 9 kms down structure from Current Adumbi Resource

Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) is pleased to announce that recent soil geochemical results have outlined four significant, undrilled mineralised trends at its 84.68%-owned Imbo Project. The focus of greenfields exploration by Loncor at Imbo East, along trend to the southeast from the 2.5 million ounce Adumbi, Kitenge and Manzako deposits (inferred mineral resources of 30.65 million tonnes grading 2.54 g/t Au) previously delineated in the northwest of the 122 square kilometre project area. Core drilling is currently being undertaken at Adumbi to increase this resource base.

Analytical results have now been received for all soil samples from the completed 5.4 kilometre by 2.3 kilometre grid, east of the Imbo River where soil samples were collected every 40 metres on lines 160 metres apart. Geological mapping, soil geochemical, rock chips and channel sampling of old colonial trenches and artisanal workings have outlined four significant mineralised trends – Esio Wapi, Museveni, Mungo Iko and Paradis – approximately 8 to 10 kilometres southeast of the Adumbi deposit (see Figures 1 and 2 below).  

At Esio Wapi, soil geochemical results have outlined a number of plus 130 ppb Au (parts per billion) gold in soil anomalies with a maximum value of 2,230 ppb Au over a 1.9 kilometre long mineralised trend (see Figure 2 below). As announced previously (see Loncor’s press release dated September 21, 2020), channel sample results from old colonial workings included 19.80 metres grading 1.58 g/t Au (open to the northeast), 8 metres grading 1.11 g/t Au and 5.0 metres grading 1.65 g/t Au in brecciated banded ironstone (BIF) and metasediment. Individual rock sample values included 15.10 g/t and 7.88 g/t Au in quartz veins, 6.39 g/t and 3.08 g/t Au in BIF and 9.06 g/t, 7.91 g/t and 3.24 g/t Au in metasediments.

On the Paradis trend, soil sample results have outlined a broad 1.0 kilometre trend (plus 130 ppb Au) with maximum value of 870 ppb Au. Significant channel samples along the Paradis trend include 6.8 metres grading 5.44 g/t Au (open to the southwest) in metasediments with quartz veins. Individual rock sample values included 22.40 g/t, 5.84 g/t and 2.31 g/t Au in quartz veins.

On the Museveni mineralized trend, anomalous soil samples and artisanal workings occur over a strike of 3.2 kilometres with a maximum value of 5,850 ppb Au in soils.  Channel samples from the artisanal workings include 6.0 metres grading 4.37 g/t Au and 1.40 metres grading 62.10 g/t Au and represent high grade quartz veins in metasediment. Individual rock sample values included 53.90 g/t, 32.80 g/t and 32.60 g/t Au in quartz veins and 18.10 g/t Au in metasediment.

On the Mungo Iko trend, soil samples have outlined a 3.1 kilometre long mineralized trend (plus 130ppb Au) with maximum value of 1,540 ppb Au. Individual rock sample values include 12.30 g/t and 3.50 g/t Au in brecciated BIF, 14.20 g/t, 4.81 g/t, and 3.68 g/t Au in metasediments, and 1.97 g/t Au in quartz veins. Further mapping is required to determine whether the eastern part of the Mungo Iko trend represents a faulted extension of the Esio Wapi trend.

Read more: https://agoracom.com/ir/LoncorResources/forums/discussion/topics/755971-loncor-continues-to-define-four-extensive-mineralized-trends-to-southeast-of-key-adumbi-deposit/messages/2305121#message

Fabled $FCO.ca Drills 12.50 Meters of 85.30 g/t Ag and 0.49 g/t Au with 1.80 Meters Grading 214.00 g/t Ag and 1.08 g/t Au at Santa Maria $RDU.ca $KTN.ca $GMBXF $EDR.ca

Posted by AGORACOM at 9:27 AM on Wednesday, February 24th, 2021
  • Results for 3rd diamond drill hole from on-going 8,000 meter drill program
  • Santa Maria structure identified from surface to -350 meters vertically
  • 12.50 Meters of 85.30 g/t Ag and 0.49 g/t Au
  • Results support the expansion of Santa Maria and increasing the present NI 43-101 resources

Fabled Silver Gold Corp. (TSXV: FCO) (OTC Pink: FBSGF) (FSE: 7NQ) (“Fabled” or the “Company”)  is pleased to announce the third diamond drill hole from the on-going 8,000 meter drill program on the Santa Maria Property in Parral, Mexico.

Peter J. Hawley, CEO and President, remarks, “The recent drill hole concludes the first ever complete drill section on the newly interpreted Santa Maria structure and clearly defines the structure from surface to -350 meters vertically, which is the deepest hole ever drilled on the property. The 12.50 meter intersection has clearly defined a footwall and hanging wall structure with corresponding elevated silver values up to over 7 ounces of silver and remains open at depth. More importantly, the structure is very conformable and intersected exactly where predicted, which bodes very well for the expansion of Santa Maria and increasing the present NI 43-101 resources on the property with only 3 drill holes drilled to date.”

Peter Hawley continues, “The data being obtained from this fence of drill holes will not only target adding silver ounces to the overall resource but also allow us to interpret and model the behavior of this robust mineralized system for future drilling as we expand outwards from the present resource.”

Table 1: Drill Hole Intercepts

Hole NoFrom (meters)To
(meters)
Width (meters)Au g/tAg g/t
SM20-003349.50362.0012.500.4985.30
Including349.50351.802.300.20123.10
Including357.40362.004.600.81128.49
 357.40359.201.801.08214.00
 361.30362.000.701.52230.00

Drill holes SM20-01, SM20-02 and SM20-03 are drilled on the same section with holes 02 and 03 targeting the sulphide intercept of the Santa Maria vein and structure.

Drill hole SM20-02 was drilled at an angle of -65 degrees for a total hole depth of 232 meters. Drill hole SM20-03 was stationed 75 meters behind the drill station for holes 01-02 and drilled at an angle of -75 degrees for a total depth of 375 meters.

The Company has completed drill holes SM20-01 – 07 for a total of 1,895 meters. Holes SM20-04 – 06 have been sampled and submitted to ALS Chihuahua Laboratory for analysis. Hole SM 20-08 is in progress.

Read More: https://agoracom.com/ir/FabledSilverGold/forums/discussion/topics/755967-fabled-drills-12-50-meters-of-85-30-g-t-ag-and-0-49-g-t-au-with-1-80-meters-grading-214-00-g-t-ag-and-1-08-g-t-au-at-santa-maria/messages/2305113#message

XPhyto Therapeutics $XPHY.ca $XPHYF Places First Order for 25-Minute Covid-19 RT-PCR Tests $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:05 AM on Wednesday, February 24th, 2021
This image has an empty alt attribute; its file name is XPHYTO-70-x-70.jpg
  • Placed First Order for its Rapid Point-Of-Care COVID-19 Test System
  • 9600 Individual Tests Ordered
  • Mid-March Delivery
  • Additional Pandemic-Focused Biosensors in Development

XPhyto Therapeutics. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company“), is pleased to announce that it has placed the first order for its rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”) from its exclusive diagnostic development partner, 3a-diagnostics GmbH (“3a”).

The first order of Covid-ID Lab is for 9,600 individual tests, which are packaged in 200 kits of 48 tests each. Delivery of the first order is expected by mid-March 2021 and will be primarily used to supply prospective distribution partners and licensees and their respective government regulators with test samples for review and evaluation. The tests will be manufactured in the German state of Baden-Württemberg.

“We are pleased to report that all steps towards the launch of Covid-ID Lab remain on track within an ambitious timeline,” said Hugh Rogers, CEO, and Director of XPhyto. “Our experienced market launch team is working quickly to bring the product to market, as well as to establish licensing and distribution partnerships. We are confident that Covid-ID Lab, as a 25-minute PCR test with minimal technical and personnel requirements, will be a stand-out product in the COVID-19 test market.”

Covid-ID Lab was designed to be a rapid, accurate, and robust COVID-19 test system with reduced operating costs and increased convenience and portability. XPhyto expects 3a to receive ISO 13485 medical device manufacturer approval by the end of February and European regulatory approval as a commercial in vitro diagnostic device (CE-IVD) for Covid-ID Lab by early March. Initial commercial manufacturing is planned for Germany, with additional capacity in other jurisdictions to follow. The sales launch in Europe is targeted for April 2021. XPhyto is currently in discussions with potential distribution and wholesale partners in Europe and the Middle East.

XPhyto and 3a are also developing a portfolio of oral biosensor screening tests for detection of bacterial and viral infectious diseases, including influenza A, group A strep, stomatitis, periimplantitis, and periodontitis. Additional pandemic-focused biosensors are in development, specifically for H1N1 (swine flu) and H5N1 (avian flu). The Company is planning the commercial launch of its first biosensor product in the second half of 2021.

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/755962-xphyto-places-first-order-for-25-minute-covid-19-rt-pcr-tests/messages/2305102#message